Influence of Proteins on the Bioavailability of Carotenoids

NCT04078646 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2021-09-23

No results posted yet for this study

Summary

A postprandial intervention study is conducted on healthy male subjects to evaluate whether the addition of proteins (why protein isolate, soy protein) can help to increase the bioavailability of carotenoids from a tomato/carrot beverage.

Conditions

  • Absorption; Chemicals
  • Healthy Diet
  • Metabolism

Interventions

OTHER

Intervention with soy protein isolate

Test meals will be served to the subjects, containing soy protein isolate: 350 mL carrot/tomato juice (50:50, v/v), with 30 g added soy protein, plus 5 ml peanut oil as morning test meal, served together with 40 g toasted bread and 20 g of cream-cheese plus 10 g margarine.

OTHER

Intervention with whey protein

Test meals will be served to the subjects, containing soy protein isolate: 350 mL carrot/tomato juice (50:50, v/v), with 30 g added whey protein isolate, plus 5 ml peanut oil as morning test meal, served together with 40 g toasted bread and 20 g of cream-cheese plus 10 g margarine.

OTHER

Intervention without protein addition

Test meals will be served to the subjects, containing soy protein isolate: 350 mL carrot/tomato juice (50:50, v/v), plus 5 ml peanut oil as morning test meal, served together with 40 g toasted bread and 20 g of cream-cheese plus 10 g margarine.

Sponsors & Collaborators

  • Laboratoires Réunis

    collaborator UNKNOWN
  • Université Catholique de Louvain

    collaborator OTHER
  • Luxembourg Institute of Science and Technology

    collaborator OTHER
  • Luxembourg Institute of Health

    lead OTHER_GOV

Principal Investigators

  • Torsten Bohn, PhD · Luxembourg Institute of Health

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-11
Primary Completion
2021-06-30
Completion
2021-06-30

Countries

  • Luxembourg

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04078646 on ClinicalTrials.gov